Wanbangde Pharmaceutical Holding Group Co., Ltd.(XSEC:002082) dropped from S&P Global BMI Index
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.46 CNY | +4.69% | -8.42% | -30.31% |
05-20 | Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Dividend for the Year 2023 | CI |
05-08 | US FDA Gives Rare Pediatric Disease Drug Designation to Wanbangde Pharmaceutical's Huperzine A | MT |
1st Jan change | Capi. | |
---|---|---|
-30.31% | 376M | |
+19.64% | 43.3B | |
+21.25% | 22.22B | |
+18.92% | 15.43B | |
+20.14% | 14.48B | |
+53.19% | 12.72B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B |
- Stock Market
- Equities
- 002082 Stock
- News Wanbangde Pharmaceutical Holding Group Co., Ltd.
- Wanbangde Pharmaceutical Holding Group Co., Ltd.(XSEC: 002082) dropped from S&P Global BMI Index